Lu-177 Therapy

Recently KIRAN offer Theranostic services (Lu-177 Therapy) for Prostate cancer (CRPC) and Neuroendocrine tumors. qlutetium with dotatate, used in peptide receptor radionuclide therapy. Specifically, it is used in the treatment of cancers which express somatostatin receptors. is a radiolabeled somatostatin analog

Lutetium (177Lu) oxodotreotide (INN) or 177Lu dotatate, brand name Lutathera, is a chelated complex of a radioisotope of the element lutetium with dotatate, used in peptide receptor radionuclide therapy. Specifically, it is used in the treatment of cancers which express somatostatin receptors.It is a radiolabeled somatostatin analog.

"Health is the most important thing you have in life!"

Contact us now to schedule an appointment.